Sponsor

OncoNano Medicine, Inc.

Clinical research sponsor

Published trials3

Recruiting shown1

Roles1

SourceClinicalTrials.gov

Clinical trials

3 shown

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.NCT06022029 · lead sponsor · 2023-10-13

RECRUITING

A Study to Evaluate Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung MalignanciesNCT05048082 · lead sponsor · 2022-04-13

COMPLETED

A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of CancerNCT03735680 · lead sponsor · 2019-08-09

COMPLETED

Sponsor roles

lead sponsor3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.